Earlier this year, the Israeli tissue repair company also received a CE Mark for VergenixFG for the treatment of chronic and surgical wounds.

Israeli regenerative medicine company Collplant Holdings Ltd. has been awarded the EU CE Mark Certification for VergenixSTR, a soft tissue repair matrix for the treatment of tendinopathy. Sales in Europe are expected to commence in the coming months. The Ness Ziona based company specializes in regenerative medicine by utilizing its proprietary plant-based rhCollagen (recombinant human collagen) technology for tissue repair products.

                                                                                                                      -  20/10/2016